Proteins and nucleic acids from meningitis/sepsis-associated Escherichia Coli

Details for Australian Patent Application No. 2012207041 (hide)

Owner Novartis Vaccines and Diagnostics, Inc. J. Craig Venter Institute, Inc.

Inventors Serino, Laura; Masignani, Vega; Norais, Nathalie; Berlanda Scorza, Francesco; Fontana, Maria Rita; Gomes Moriel, Danilo; Tettelin, Herve; Pizza, Mariagrazia

Agent FB Rice

Pub. Number AU-A-2012207041

Parent 2006214064

Filing date 26 July 2012

Wipo publication date 16 August 2012

International Classifications

C07K 14/245 Peptides having more than 20 amino acids

A61K 39/02 Medicinal preparations containing antigens or antibodies - Bacterial antigens

C12N 15/00 Mutation or genetic engineering

Event Publications

9 August 2012 Complete Application Filed

16 August 2012 Application Open to Public Inspection

  Published as AU-A-2012207041

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012207042-Method and apparatus for drilling and servicing subterranean wells with rotating coiled tubing

2012207040-Multimeric proteins and methods of making and using same